Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Sokol

Showing results (11-20 of 321) with videos related to

Pageof 33
Sort By:
Cell Reports. Medicine|August 2, 2021
Butyrate, a new microbiota-dependent player in CD8+ T cells immunity and cancer therapy?Camille Danne, Harry Sokol
Medecine Sciences : M/S|April 2, 2019
[Tryptophan and metabolic syndrome, a new challenge for health]Allison Agus, Harry Sokol
Cell Reports|July 11, 2020
Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 InfectionFrançois Trottein, Harry Sokol
Nature Medicine|September 15, 2022
Understanding and predicting the efficacy of FMTAonghus Lavelle, Harry Sokol
United European Gastroenterology Journal|November 10, 2020
Expert centres for faecal microbiota transplantation: The guarantee for safe and effective use of faecal transplantsNicolas Benech, Harry Sokol
La Revue Du Praticien|April 21, 2010
[Acute diarrhea in the adult]Harry Sokol, Laurent Beaugerie
Liver International : Official Journal of the International Association for the Study of the Liver|January 10, 2012
Colorectal neoplasia in PSC-IBD patients: are times changing?Harry Sokol, Olivier Chazouilleres
Inflammatory Bowel Diseases|May 27, 2014
Beneficial effects of exclusive enteral nutrition in Crohn's disease are not mediated by Faecalibacterium prausnitziiHarry Sokol, Philippe Langella
Nature Reviews. Gastroenterology & Hepatology|June 14, 2022
Specific gut microbiota taxa as a key source of variability in colitis modelNicolas Benech, Harry Sokol
Gut|December 18, 2024
<i>Faecalibacterium prausnitzii</i>: one species with multiple potential implications in cancer researchRodrigo Formiga, Harry Sokol
Pageof 33

Showing results (11-20 of 321) with videos related to

Sort By:
Pageof 33
Cell Reports. Medicine|August 2, 2021
Butyrate, a new microbiota-dependent player in CD8+ T cells immunity and cancer therapy?Camille Danne, Harry Sokol
Medecine Sciences : M/S|April 2, 2019
[Tryptophan and metabolic syndrome, a new challenge for health]Allison Agus, Harry Sokol
Cell Reports|July 11, 2020
Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 InfectionFrançois Trottein, Harry Sokol
Nature Medicine|September 15, 2022
Understanding and predicting the efficacy of FMTAonghus Lavelle, Harry Sokol
United European Gastroenterology Journal|November 10, 2020
Expert centres for faecal microbiota transplantation: The guarantee for safe and effective use of faecal transplantsNicolas Benech, Harry Sokol
La Revue Du Praticien|April 21, 2010
[Acute diarrhea in the adult]Harry Sokol, Laurent Beaugerie
Liver International : Official Journal of the International Association for the Study of the Liver|January 10, 2012
Colorectal neoplasia in PSC-IBD patients: are times changing?Harry Sokol, Olivier Chazouilleres
Inflammatory Bowel Diseases|May 27, 2014
Beneficial effects of exclusive enteral nutrition in Crohn's disease are not mediated by Faecalibacterium prausnitziiHarry Sokol, Philippe Langella
Nature Reviews. Gastroenterology & Hepatology|June 14, 2022
Specific gut microbiota taxa as a key source of variability in colitis modelNicolas Benech, Harry Sokol
Gut|December 18, 2024
<i>Faecalibacterium prausnitzii</i>: one species with multiple potential implications in cancer researchRodrigo Formiga, Harry Sokol
Pageof 33